Lyme disease has been a nationally notifiable condition in the United States since 1991 without a U.S. Food and Drug Administration (FDA) approved vaccine.
Initially identified in Lyme, Connecticut, in 1976, over 63,000 cases of Lyme disease were reported by state health departments and the District of Columbia in 2022, primarily in the northeastern U.S.
However, based on the continued positive progress of an innovative multivalent protein subunit Lyme disease vaccine candidate, nature lovers may soon gain protection from this Black-legged tick-borne disease.
Lyme Disease Vaccine Candidate Approaches Approval
Another Country Offers Second-Gen Malaria Vaccine
In collaboration with UNICEF, the World Health Organization (WHO), and Gavi, South Sudan's Ministry of Health, today announced the official launch of a nationwide R21/Matrix-M™ malaria vaccine distribution.
First National RSV Vaccination Program Launches in the UK
The United Kingdom (UK) has announced that it will be the first country to implement a national program using the same vaccine to protect newborns following vaccinating pregnant women and older adults against Respiratory Syncytial Virus (RSV).
Each year in the UK, RSV infections are responsible for 20 to 30 infant deaths and around 9,000 hospital admissions in those aged over 75.
National RSV Vaccination Program Launches in the UK
The United Kingdom (UK) has announced that it will be the first country to implement a national program using the same vaccine to protect newborns following vaccinating pregnant women and older adults against Respiratory Syncytial Virus (RSV).
Each year in the UK, RSV infections are responsible for 20 to 30 infant deaths and around 9,000 hospital admissions in those aged over 75.
Odds of IBS, Functional Dyspepsia Increased After Acute Gastroenteritis Episode
Significantly increased odds seen for irritable bowel syndrome, functional dyspepsia compared with nonexposed controls